We are live on ! Find out more
TG

Tom Gayner Markel Group

AUM $13.1B
1-Year Est. Return 15.62%
 

Tom Gayner is the CEO of Markel Group and long-time steward of its public equity portfolio. Often compared to a smaller-scale Berkshire-style model, Markel combines insurance operations with a carefully selected book of common stocks. Gayner is known for a patient, owner-oriented philosophy and for writing clearly about compounding, culture, and long-term business ownership.

This Fund
S&P 500
This Quarter Est. Return
+2.59%
1 Year Est. Return
+15.62%
3 Year Est. Return
+68.04%
5 Year Est. Return
+83.51%
10 Year Est. Return
+378.4%
AUM
$3.26B
AUM Growth
+$93.4M
Cap. Flow
+$18.1M
Cap. Flow %
0.55%
Top 10 Hldgs %
44.62%
Holding
115
New
6
Increased
27
Reduced
55
Closed
10

Top Buys

Rank Stock Value
1
UL icon
Unilever
UL
+$15.6M
2
SLB icon
SLB Ltd
SLB
+$7.78M
3
CPRT icon
Copart
CPRT
+$7.45M
4
CVS icon
CVS Health
CVS
+$6.78M
5
FWONA icon
Liberty Media Series A
FWONA
+$5.52M

Sector Composition

Rank Sector Weight
1 Financials 32.12%
2 Consumer Discretionary 14.4%
3 Consumer Staples 13.79%
4 Healthcare 13.39%
5 Industrials 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRSL
51
Brightstar Lottery PLC
BRSL
$2.21B
$12.9M 0.4%
915,000
-116,700
-11% -$1.81M
HAS icon
52
Hasbro
HAS
$13.3B
$12.2M 0.37%
219,000
+200
+0.1% +$10.6K
CVX icon
53
Chevron
CVX
$397B
$11.7M 0.36%
98,000
+3,000
+3% +$349K
ACNT icon
54
Ascent Industries
ACNT
$133M
$11.3M 0.35%
785,343
BRO icon
55
Brown & Brown
BRO
$24.9B
$11.2M 0.35%
731,256
PEP icon
56
PepsiCo
PEP
$198B
$10.8M 0.33%
129,300
-1,000
-0.8% -$81.2K
BX icon
57
Blackstone
BX
$108B
$10.6M 0.33%
325,061
+25,067
+8% +$800K
EMR icon
58
Emerson Electric
EMR
$87.5B
$10.6M 0.32%
158,000
-4,900
-3% -$322K
BF.B icon
59
Brown-Forman Class B
BF.B
$13.3B
$9.45M 0.29%
329,297
-3,116
-0.9% -$81.7K
PM icon
60
Philip Morris
PM
$300B
$9.37M 0.29%
114,500
L icon
61
Loews
L
$22.8B
$9.25M 0.28%
210,000
-25,000
-11% -$1.12M
NTRS icon
62
Northern Trust
NTRS
$34.3B
$9.18M 0.28%
140,000
MAT icon
63
Mattel
MAT
$4.17B
$8.95M 0.27%
223,000
+37,500
+20% +$1.49M
NSC icon
64
Norfolk Southern
NSC
$78.8B
$8.94M 0.27%
92,000
-2,400
-3% -$223K
NKE icon
65
Nike
NKE
$60.7B
$8.86M 0.27%
240,000
-800
-0.3% -$30.2K
FDS icon
66
Factset
FDS
$10.8B
$8.84M 0.27%
82,000
+26,000
+46% +$2.75M
ACN icon
67
Accenture
ACN
$114B
$8.77M 0.27%
110,000
-4,400
-4% -$361K
E icon
68
ENI
E
$79.5B
$8.38M 0.26%
167,000
CG icon
69
Carlyle Group
CG
$17.5B
$7.84M 0.24%
223,000
+27,000
+14% +$947K
MOS icon
70
The Mosaic Company
MOS
$7.61B
$7.75M 0.24%
155,000
PG icon
71
Procter & Gamble
PG
$339B
$7.66M 0.24%
95,000
+53,100
+127% +$4.18M
SEIC icon
72
SEI Investments
SEIC
$13.4B
$7.63M 0.23%
227,000
+27,000
+14% +$918K
ECL icon
73
Ecolab
ECL
$80.1B
$7.56M 0.23%
70,000
+13,600
+24% +$1.42M
KKR icon
74
KKR & Co
KKR
$97.6B
$7.38M 0.23%
323,000
+33,000
+11% +$799K
CVS icon
75
CVS Health
CVS
$119B
$7.19M 0.22%
+96,000
New +$6.78M

Similar funds

Tom Gayner's Q1 2014 Portfolio in Review

As of Q1 2014, Tom Gayner held 115 positions worth $3.26B, up 3% from $3.16B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Tom Gayner's Q1 2014 filing shows 6 new, 27 increased, 55 reduced and 10 closed positions. Its largest new stake was CVS Health: 96,000 shares worth $7.19M. The largest sale was Alliance Holdings GP, an estimated $9.76M.

By sector, the portfolio is most concentrated in Financials at 32% of assets, up from 32% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

  • Tom Gayner's largest Q1 2014 buy was CVS Health: 96,000 shares worth $7.19M.
  • Tom Gayner added most to Unilever in Q1 2014, an estimated $15.6M increase.
  • Tom Gayner's biggest Q1 2014 reduction was CarMax, cutting an estimated $2.95M.
  • Tom Gayner fully exited Alliance Holdings GP in Q1 2014, selling an estimated $9.76M.
  • Tom Gayner's ten largest holdings make up 45% of its $3.26B portfolio in Q1 2014.
  • Tom Gayner opened 6 new positions and closed 10 in Q1 2014.
  • Tom Gayner's portfolio value rose 3% quarter-over-quarter to $3.26B.

Based on Markel Group's 13F filing for Q1 2014, filed 13 May 2014.